(2S,4R)-4-hydroxy-1-[(2R)-2-[3-[2-[3-[(3S)-4-[6-(2-hydroxyphenyl)-3-(methylamino)pyridazin-4-yl]-3-methylpiperazin-1-yl]pyrrolidin-1-yl]ethoxy]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide

C47H60N10O6S — CID 170068324

IUPAC(2S,4R)-4-hydroxy-1-[(2R)-2-[3-[2-[3-[(3S)-4-[6-(2-hydroxyphenyl)-3-(methylamino)pyridazin-4-yl]-3-methylpiperazin-1-yl]pyrrolidin-1-yl]ethoxy]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide
SMILESCNc1nnc(-c2ccccc2O)cc1N1CCN(C2CCN(CCOc3cc([C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)N[C@@H](C)c4ccc(-c5scnc5C)cc4)C(C)C)on3)C2)C[C@@H]1C
InChIInChI=1S/C47H60N10O6S/c1-28(2)43(47(61)57-26-35(58)21-39(57)46(60)50-30(4)32-11-13-33(14-12-32)44-31(5)49-27-64-44)41-23-42(53-63-41)62-20-19-54-16-15-34(25-54)55-17-18-56(29(3)24-55)38-22-37(51-52-45(38)48-6)36-9-7-8-10-40(36)59/h7-14,22-23,27-30,34-35,39,43,58-59H,15-21,24-26H2,1-6H3,(H,48,52)(H,50,60)/t29-,30-,34?,35+,39-,43+/m0/s1
InChIKeyBDSXEYHIDSPNIH-YLNGNUENSA-N
MW893.13 g/mol
LogP5.55
Rot. Bonds15

About (2S,4R)-4-hydroxy-1-[(2R)-2-[3-[2-[3-[(3S)-4-[6-(2-hydroxyphenyl)-3-(methylamino)pyridazin-4-yl]-3-methylpiperazin-1-yl]pyrrolidin-1-yl]ethoxy]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide

(2S,4R)-4-hydroxy-1-[(2R)-2-[3-[2-[3-[(3S)-4-[6-(2-hydroxyphenyl)-3-(methylamino)pyridazin-4-yl]-3-methylpiperazin-1-yl]pyrrolidin-1-yl]ethoxy]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide (PubChem CID 170068324) has the molecular formula C47H60N10O6S and a molecular weight of 893.13 g/mol. Its IUPAC name is (2S,4R)-4-hydroxy-1-[(2R)-2-[3-[2-[3-[(3S)-4-[6-(2-hydroxyphenyl)-3-(methylamino)pyridazin-4-yl]-3-methylpiperazin-1-yl]pyrrolidin-1-yl]ethoxy]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide.

Molecular Properties

Compound Name(2S,4R)-4-hydroxy-1-[(2R)-2-[3-[2-[3-[(3S)-4-[6-(2-hydroxyphenyl)-3-(methylamino)pyridazin-4-yl]-3-methylpiperazin-1-yl]pyrrolidin-1-yl]ethoxy]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide
PubChem CID170068324
Molecular FormulaC47H60N10O6S
Molecular Weight893.13 g/mol
Exact Mass892.44
IUPAC Name(2S,4R)-4-hydroxy-1-[(2R)-2-[3-[2-[3-[(3S)-4-[6-(2-hydroxyphenyl)-3-(methylamino)pyridazin-4-yl]-3-methylpiperazin-1-yl]pyrrolidin-1-yl]ethoxy]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide
SMILESCNc1nnc(-c2ccccc2O)cc1N1CCN(C2CCN(CCOc3cc([C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)N[C@@H](C)c4ccc(-c5scnc5C)cc4)C(C)C)on3)C2)C[C@@H]1C
InChIInChI=1S/C47H60N10O6S/c1-28(2)43(47(61)57-26-35(58)21-39(57)46(60)50-30(4)32-11-13-33(14-12-32)44-31(5)49-27-64-44)41-23-42(53-63-41)62-20-19-54-16-15-34(25-54)55-17-18-56(29(3)24-55)38-22-37(51-52-45(38)48-6)36-9-7-8-10-40(36)59/h7-14,22-23,27-30,34-35,39,43,58-59H,15-21,24-26H2,1-6H3,(H,48,52)(H,50,60)/t29-,30-,34?,35+,39-,43+/m0/s1
InChIKeyBDSXEYHIDSPNIH-YLNGNUENSA-N
XLogP5.55
TPSA185.55 Ų
H-Bond Donors4
H-Bond Acceptors15
Rotatable Bonds15
Heavy Atoms64
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500893.13
LogP ≤ 55.55
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1015

Analyze (2S,4R)-4-hydroxy-1-[(2R)-2-[3-[2-[3-[(3S)-4-[6-(2-hydroxyphenyl)-3-(methylamino)pyridazin-4-yl]-3-methylpiperazin-1-yl]pyrrolidin-1-yl]ethoxy]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S,4R)-4-hydroxy-1-[(2R)-2-[3-[2-[3-[(3S)-4-[6-(2-hydroxyphenyl)-3-(methylamino)pyridazin-4-yl]-3-methylpiperazin-1-yl]pyrrolidin-1-yl]ethoxy]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide?
The IUPAC name of (2S,4R)-4-hydroxy-1-[(2R)-2-[3-[2-[3-[(3S)-4-[6-(2-hydroxyphenyl)-3-(methylamino)pyridazin-4-yl]-3-methylpiperazin-1-yl]pyrrolidin-1-yl]ethoxy]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide (CID 170068324) is (2S,4R)-4-hydroxy-1-[(2R)-2-[3-[2-[3-[(3S)-4-[6-(2-hydroxyphenyl)-3-(methylamino)pyridazin-4-yl]-3-methylpiperazin-1-yl]pyrrolidin-1-yl]ethoxy]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide.
What is the SMILES notation for (2S,4R)-4-hydroxy-1-[(2R)-2-[3-[2-[3-[(3S)-4-[6-(2-hydroxyphenyl)-3-(methylamino)pyridazin-4-yl]-3-methylpiperazin-1-yl]pyrrolidin-1-yl]ethoxy]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide?
The canonical SMILES for (2S,4R)-4-hydroxy-1-[(2R)-2-[3-[2-[3-[(3S)-4-[6-(2-hydroxyphenyl)-3-(methylamino)pyridazin-4-yl]-3-methylpiperazin-1-yl]pyrrolidin-1-yl]ethoxy]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide is CNc1nnc(-c2ccccc2O)cc1N1CCN(C2CCN(CCOc3cc([C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)N[C@@H](C)c4ccc(-c5scnc5C)cc4)C(C)C)on3)C2)C[C@@H]1C.
What is the InChIKey of (2S,4R)-4-hydroxy-1-[(2R)-2-[3-[2-[3-[(3S)-4-[6-(2-hydroxyphenyl)-3-(methylamino)pyridazin-4-yl]-3-methylpiperazin-1-yl]pyrrolidin-1-yl]ethoxy]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide?
The InChIKey is BDSXEYHIDSPNIH-YLNGNUENSA-N. The full InChI is InChI=1S/C47H60N10O6S/c1-28(2)43(47(61)57-26-35(58)21-39(57)46(60)50-30(4)32-11-13-33(14-12-32)44-31(5)49-27-64-44)41-23-42(53-63-41)62-20-19-54-16-15-34(25-54)55-17-18-56(29(3)24-55)38-22-37(51-52-45(38)48-6)36-9-7-8-10-40(36)59/h7-14,22-23,27-30,34-35,39,43,58-59H,15-21,24-26H2,1-6H3,(H,48,52)(H,50,60)/t29-,30-,34?,35+,39-,43+/m0/s1.
What are the key properties of (2S,4R)-4-hydroxy-1-[(2R)-2-[3-[2-[3-[(3S)-4-[6-(2-hydroxyphenyl)-3-(methylamino)pyridazin-4-yl]-3-methylpiperazin-1-yl]pyrrolidin-1-yl]ethoxy]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide?
(2S,4R)-4-hydroxy-1-[(2R)-2-[3-[2-[3-[(3S)-4-[6-(2-hydroxyphenyl)-3-(methylamino)pyridazin-4-yl]-3-methylpiperazin-1-yl]pyrrolidin-1-yl]ethoxy]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide has a molecular weight of 893.13 g/mol, XLogP of 5.55, 15 rotatable bonds, 4 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for (2S,4R)-4-hydroxy-1-[(2R)-2-[3-[2-[3-[(3S)-4-[6-(2-hydroxyphenyl)-3-(methylamino)pyridazin-4-yl]-3-methylpiperazin-1-yl]pyrrolidin-1-yl]ethoxy]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide is sourced from PubChem (CID 170068324), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).